Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Clinical Genitourinary Cancer|March 8, 2020
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional StudyMarco Bandini, Filippo Pederzoli, Russell Madison, et al.
European Urology|November 12, 2019
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant HistologiesAndrea Necchi, Daniele Raggi, Andrea Gallina, et al.
Journal of Gastrointestinal Oncology|October 12, 2019
Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsyGerald Li, Dean Pavlick, Jon H Chung, et al.
Nature Communications|November 18, 2018
RET rearrangements are actionable alterations in breast cancerBhavna S Paratala, Jon H Chung, Casey B Williams, et al.
European Urology|December 29, 2019
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 StudyAndrea Necchi, Marco Bandini, Giuseppina Calareso, et al.
JCO Precision Oncology|February 9, 2022
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational StudySteven F Powell, Elie G Dib, Jonathan S Bleeker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2021
Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance MechanismsHanna Tukachinsky, Russell W Madison, Jon H Chung, et al.
European Urology|January 22, 2020
Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the BladderAndrea Necchi, Russell Madison, Daniele Raggi, et al.
Translational Oncology|August 1, 2021
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitorsJonathan W Riess, Shaila Rahman, Waleed Kian, et al.
JCO Precision Oncology|September 11, 2020
BRAF in Lung Cancers: Analysis of Patient Cases Reveals Recurrent BRAF Mutations, Fusions, Kinase Duplications, and Concurrent AlterationsYuri Sheikine, Dean Pavlick, Samuel J Klempner, et al.
Pageof 9